Global HIV News
Pharma Industry 03/07/2009
GSK spends £23.2 million to bag BMS products in Middle East
GlaxoSmithKline is continuing with its strategy of expanding in the emerging markets and has acquired the branded generics business of Bristol-Myers Squibb in five Middle East countries.
World Policy 03/07/2009
Levy for air travellers to fight AIDS
The scheme, which may involve an automatic contribution with an opt-out, could be launched by May 2010 as a complement to an air ticket tax that has raised nearly $1bn since it was was launched in France and a handful of other countries three years ago.
Prevention 03/07/2009
Canadian-made HIV vaccine close to human trial
It has been 20 years in the making but researchers at the University of Western Ontario say they're confident their HIV vaccine is only months away from being approved for human trials.
Pharma Industry 03/07/2009
Report: Drug companies violating WHO ethics on advertising in East Africa
Of the brochures distributed at medical facilities, none met six standard criteria as set out by the WHO for ethical advertising of medicines. Only 16 percent of advertisements released to the general public did so.
Access to treatment 03/07/2009
Kenya pressured to implement anti-counterfeit law despite access fears
An influential manufacturers’ lobbying group in Kenya is pushing the government to start enforcing an anti-counterfeiting law within weeks, despite fears from public health advocates that the new rules will impede access to generic drugs and set an unwanted precedent in East Africa.
Our Latest News
Jobs 16/06/2009
Internship
Reporting to the EATG Programme Assistant, the Intern will support the development and strengthening of EATG activities in the key areas of Communication, Capacity Development and Policy, via assisting in implementation of projects and maintaining content of the EATG website.
Press Releases 16/06/2009
Aids Action Europe: 5 years of European collaboration in response to the HIV epidemic
Aids Action Europe press release on 5 years of collaboration fighting against HIV epidemic
Press Releases 12/06/2009
EATG and GNP+ Press Release on Czech Travel Restrictions for People Living with HIV
(Amsterdam/Bruxelles) - The Global Network of people living with HIV/AIDS (GNP+) and the European AIDS Treatment Group (EATG) are concerned by the new immigration procedures of the Czech Republic.
Open letters 11/06/2009
Letter on Czech Republic Visa Restrictions for People Living with HIV
The European AIDS Treatment Group strongly condemns the introduction by the Czech Government of a visa entry requirement that would completely exclude from entry to the Czech Republic people from certain countries with HIV, tuberculosis and syphilis.
Positions 03/06/2009
EATG calls for more research and funding for prevention
Brussels, Belgium – June 01, 2009 – The European AIDS Treatment Group (EATG) released today a comprehensive policy paper on HIV and AIDS prevention.
Statements 18/05/2009
World Aids Vaccine Day, May 18th
Sustaining the search for an AIDS vaccine is the right thing to do. One look at the statistics tells us that we are still not winning the fight against HIV/AIDS.
Events 15/05/2009
Frontiers of Retrovirology
"Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts", Montpellier, France, 21-23 September 2009.
Other Reports and Publications 27/04/2009
HIV/AIDS and Migration: Community Recommendations
Based on the European conference “The Right to HIV/AIDS Prevention, Treatment, Care and Support for Migrants and Ethnic Minorities in Europe: The Community Perspective”, Lisbon, 7-8 June 2007
Welcome to the EATG
Established in 1992, the European AIDS Treatment Group (EATG) is a European network of nationally-based activists. As a European patient-led advocacy organisation, it has been at the forefront of the development of the civil society response to the HIV/AIDS epidemic in Europe. It represents and defends the treatment-related interests of people living with HIV and AIDS.
The EATG’s mission is to achieve the fastest possible access to state of the art medical products, devices and diagnostic tests that prevent or treat HIV infection or improve the quality of life of people living with HIV, or who are at risk of HIV infection.
In responding to HIV, the EATG also considers diseases frequently seen as co-infection in people with HIV, as well as other health issues that increase the risk of HIV.
